According to Swedish Orphan Biovitrum's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 2.49. At the end of 2024 the company had a P/S ratio of 4.03.
Year | P/S ratio | Change |
---|---|---|
2024 | 4.03 | -5.44% |
2023 | 4.27 | 28.26% |
2022 | 3.33 | -2.75% |
2021 | 3.42 | -3.8% |
2020 | 3.55 | 10.7% |
2019 | 3.21 | -42.55% |
2018 | 5.59 | 18.32% |
2017 | 4.72 | -9.01% |
2016 | 5.19 | -53.44% |
2015 | 11.2 | 51% |
2014 | 7.39 | -10.75% |
2013 | 8.27 | 60.36% |
2012 | 5.16 | 520.95% |
2011 | 0.8310 | -63.49% |
2010 | 2.28 |